SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Director/PDMR Shareholding

13 Feb 2026 16:15

RNS Number : 0141T
Porvair PLC
13 February 2026
 

13 February 2026

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

 

Director/PDMR Shareholding

The Company announces that on 11 February 2026 options were granted under the Group's Long Term Share Plan 2018 ("LTSP") to the Executive Directors. Options under the LTSP were granted as follows:

Director

Position

Options awarded under the LTSP

Grant date

Vesting date

Minimum holding period

Total options held, including SAYE options

Hooman Caman Javvi

CEO

88,110

11 February 2026

11 February 2029

2 years after vesting

216,751

James Mills

CFO

59,680

297,931

 

These options, with a 2 pence exercise price, can only be exercised in full if the Remuneration Committee is satisfied that in the financial year ending 30 November 2028 ("FY2028") the Group has achieved Adjusted EPS of at least 64.3 pence, which is a 15% compound annual growth rate from the Adjusted EPS in the year ended 30 November 2025. 20% of the award will vest if the Group has achieved Adjusted EPS of 47.6 pence in FY2028. A sliding scale will operate if Adjusted EPS are between 47.6 pence and 64.3 pence. No shares vest if the Adjusted EPS in FY2028 is below 47.6 pence.

After the vesting period, before the end of the two-year holding period, the option holder may exercise the option but may only sell sufficient shares to settle the option price and the income tax payable. The options may be exercised after the vesting period up until 11 February 2036. Claw-back and malus provisions apply.

Following these grants, the total number of LTSP and SAYE options in issue is 871,643, representing approximately 1.8% of the shares in issue.

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Andrew Douglass, Group Company Secretary

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

The information below (set out in accordance with the requirements of the Market Abuse Regulation) provides further detail:

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Hooman Caman Javvi

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Options over Ordinary Shares of 2 pence under the Porvair plc Long Term Share Plan 

 

GB0006963689

b.

Nature of the transaction

Grant of options

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

n/a

88,110

d.

Aggregated information

· Aggregated volume

· Price

 

 

n/a - single transaction

e.

Date of the transaction

11 February 2026

f.

Place of the transaction

Outside a trading venue 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

James Mills

2.

Reason for the notification

a.

Position/status

CFO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Options over Ordinary Shares of 2 pence under the Porvair plc Long Term Share Plan 

 

GB0006963689

b.

Nature of the transaction

Grant of options

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

n/a

59,680

d.

Aggregated information

· Aggregated volume

· Price

 

 

n/a - single transaction

e.

Date of the transaction

11 February 2026

f.

Place of the transaction

Outside a trading venue 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGMZKFVGVZM
Date   Source Headline
22nd May 20269:16 amRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSAppointment of Joint Corporate Broker
24th Apr 20264:30 pmRNSHolding(s) in Company
24th Apr 202610:15 amRNSHolding(s) in Company
14th Apr 20264:29 pmRNSResults of AGM
14th Apr 20267:00 amRNSAGM Trading Update
1st Apr 20264:30 pmRNSTotal Voting Rights
26th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSNotice of AGM
11th Mar 20267:00 amRNSNotice of AGM
3rd Mar 202610:00 amRNSHolding(s) in Company
27th Feb 20263:00 pmRNSTotal Voting Rights
24th Feb 20265:45 pmRNSDirector/PDMR Shareholding
19th Feb 20261:00 pmRNSHolding(s) in Company
17th Feb 20262:00 pmRNSDirector/PDMR Shareholding
13th Feb 20264:15 pmRNSDirector/PDMR Shareholding
9th Feb 20263:45 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSFull Year Results
6th Feb 20264:00 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
30th Jan 202612:00 pmRNSTotal Voting Rights
26th Jan 202610:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSAcquisition of Drache Umwelttechnik GmbH
6th Jan 20267:00 amRNSBlock listing Return
17th Dec 202510:00 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSYear end trading update and notice of results
11th Dec 20254:00 pmRNSHolding(s) in Company
5th Dec 20259:30 amRNSHolding(s) in Company
2nd Dec 202511:00 amRNSHolding(s) in Company
27th Oct 20257:00 amRNSTotal Voting Rights
7th Oct 20257:00 amRNSBlock Listing Return
25th Sep 20257:00 amRNSBoard Changes
16th Sep 20257:00 amRNSNine Month Trading Update
4th Sep 20257:30 amRNSHolding(s) in Company
23rd Jul 20255:30 pmRNSHolding(s) in Company
23rd Jul 20259:00 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSInterim Results
19th Jun 202510:04 amRNSBlocklisting Application
17th Jun 20254:40 pmRNSHolding(s) in Company
29th May 202512:00 pmRNSHolding(s) in Company
28th Apr 20259:00 amRNSHolding(s) in Company
25th Apr 20259:00 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSChange of Remuneration Committee Chair
15th Apr 20253:00 pmRNSHolding(s) in Company
15th Apr 20252:43 pmRNSAGM resolutions
15th Apr 20257:00 amRNSAGM Trading Update
9th Apr 202512:00 pmRNSBlock listing Interim Review
7th Apr 20258:00 amRNSDirector Declaration
4th Apr 202510:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.